Radius Health Inc
(NASDAQ : RDUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.32%356.951.2%$818.54m
AMGNAmgen Inc.
-1.11%189.631.2%$542.78m
CELGCelgene Corporation
-0.38%85.021.2%$517.50m
GILDGilead Sciences, Inc.
-0.10%76.970.9%$472.97m
VRTXVertex Pharmaceuticals Incorporated
-1.38%177.641.9%$311.21m
REGNRegeneron Pharmaceuticals, Inc.
-0.26%366.802.6%$283.72m
ILMNIllumina, Inc.
0.40%310.343.5%$265.50m
SRPTSarepta Therapeutics, Inc.
-0.33%135.0816.6%$231.35m
BLUEBluebird Bio, Inc.
1.20%181.1015.7%$204.36m
ALXNAlexion Pharmaceuticals, Inc.
-0.10%134.952.0%$176.36m
NKTRNektar Therapeutics
-1.28%48.455.6%$171.83m
EXASExact Sciences Corporation
0.47%67.9325.4%$159.51m
EXELExelixis, Inc.
-0.61%21.216.4%$135.56m
BMRNBioMarin Pharmaceutical Inc.
-1.09%101.754.4%$123.78m
AAgilent Technologies, Inc.
0.09%64.211.5%$122.73m

Company Profile

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The firm's lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.